Promising meningioma drug trial halted early – what we know
NCT ID NCT05130866
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This study tested a drug called REC-2282 in people with a rare genetic condition (NF2) that causes brain tumors called meningiomas. The trial aimed to see if the drug could slow tumor growth. It was stopped early, but the results may still help researchers understand how to treat these hard-to-manage tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Columbia University
New York, New York, 10032, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
House Institute
Los Angeles, California, 90057, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Nicklaus Children's Hospital
Miami, Florida, 33155, United States
-
Sarah Cannon Cancer Institute - HCA Midwest
Overland Park, Kansas, 66211, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of California Los Angeles
Los Angeles, California, 90095, United States
-
University of Florida
Gainesville, Florida, 32611, United States
-
University of Minnesota / Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.